KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) FCF Margin: 2013-2025

Historic FCF Margin for Xenon Pharmaceuticals (XENE) over the last 8 years, with Mar 2025 value amounting to -822.60%.

  • Xenon Pharmaceuticals' FCF Margin was N/A to -822.60% in Q1 2025 from the same period last year, while for Mar 2025 it was -1,179.78%, marking a year-over-year change of. This contributed to the annual value of -1,101.57% for FY2022, which is 71348.00% down from last year.
  • Xenon Pharmaceuticals' FCF Margin amounted to -822.60% in Q1 2025, which was up 96.47% from -23,324.24% recorded in Q3 2022.
  • In the past 5 years, Xenon Pharmaceuticals' FCF Margin registered a high of -212.64% during Q1 2022, and its lowest value of -23,324.24% during Q3 2022.
  • Its 1-year average for FCF Margin is -822.60%, with a median of -822.60% in 2025.
  • Examining YoY changes over the last 5 years, Xenon Pharmaceuticals' FCF Margin showed a top increase of 27,180bps in 2022 and a maximum decrease of 2,298,580bps in 2022.
  • Over the past 3 years, Xenon Pharmaceuticals' FCF Margin (Quarterly) stood at -567.94% in 2021, then tumbled by 2,298,580bps to -23,324.24% in 2022, then reached -822.60% in 2025.
  • Its FCF Margin was -822.60% in Q1 2025, compared to -23,324.24% in Q3 2022 and -3,248.51% in Q2 2022.